Intersect Ent Gmbh

Advanced Cardiovascular Systems, Inc.

Abbott Cardiovascular Systems, Inc.

Vacu-site Medical, Inc.

Other

Seros Medical, LLC

Anthony J Abbate

David C Gale

Bin Huang

Gail M Zaler

Klaus Kleine

Donald J Eaton

Stephen D Pacetti

Jeong Soo Lee

Svava Maria Atladottir

Timothy A Limon

Vijaykumar Reddy Rajasekhar

David Myung

John Joseph Stankus

Srinivasan Sridharan

Richard E Kaufman

Stephen R Dugan

Edward E Manche

Jeffrey David Royal

Gail Meredith Zaler

Richard Eric Kaufman

James Su

Jerome Hester

Mark W Mewissen

Susan P Stimson

Rahul Bitla

Tu Duc Ngo

Diego Javier Garnica

Lisa Earnhardt

Syed FA Hossainy

Systems and methods for delivering a therapeutic agent to target tissue using a plurality of drug delivery platforms each having a polymer scaffold and the therapeutic agent contained within the polymer scaffold. Each drug delivery platform of the plurality of drug delivery platforms is implanted into the target tissue, allowing the therapeutic agent to elute from each drug delivery platform of the plurality of drug delivery platforms for a target period of time, delivering a therapeutic dose of the therapeutic agent for the target period of time. Each drug delivery platform of the plurality of drug delivery platforms is allowed to biodegrade within the target tissue.

Submucosal bioresorbable drug eluting platform

Described here are delivery devices for delivering one or more implants to the body, and methods of using. The delivery devices may deliver implants to a variety of locations within the body, for a number of different uses. In some variations, the delivery devices have a cannula with one or more curved sections. In some variations, a pusher may be used to release one or more implants from the cannula. In some variations, one or more of the released implants may be a self-expanding device. Methods of delivering implants to one or more sinus cavities are also described here.

Self-expanding devices and methods therefor

Described here are systems, devices, and methods for delivery of an implant to a bodily cavity. The implant may include a hub and a plurality of legs, and may be moveable between a low-profile and expanded configuration. The systems may include a crimping device having a crimping member with a plurality of arms. The plurality of arms may engage the plurality of legs of the implant, and may move the legs to move the implant to the low-profile configuration. In some instances a delivery device may aid in crimping and/or delivery of the implant.

Systems, devices, and method for treating a sinus condition

Described here are expandable devices and methods for using them. The devices generally comprise a hub and a plurality of legs extending therefrom. In some variations, the hub may comprise one or more domed portions, tapered portions, or the like. The legs may comprise one or more straight segments, one or more curved segments, or a combination thereof. The devices may comprise one or more polymers, and/or one or more portions of the device may be configured to biodegrade. In other variations, the device may be configured to release one or more drugs therefrom. Additionally, in some variations the devices may be configured to be self-expandable from a low-profile configuration to an expanded configuration.

Expandable devices and methods for treating a nasal or sinus condition

This invention relates to a device and method for the vacuum-assisted delivery of drugs through an intact surface membrane of an organ.

Vacuum-assisted drug delivery device and method

Systems, devices, and methods may be used for delivery of an implant to a bodily cavity. The implant may include a hub and a plurality of legs, and may be moveable between a low-profile and expanded configuration. The systems may include a crimping device having a crimping member with a plurality of arms. The plurality of arms may engage the plurality of legs of the implant, and may move the legs to move the implant to the low-profile configuration. In some instances a delivery device may aid in crimping and/or delivery of the implant.

Methods and systems of fabricating a polymeric stent are disclosed herein.

Manufacturing process for polymeric stents

Various embodiments of stents with radiopaque markers disposed within depots in the stent, are described herein.

Stents with radiopaque markers

Growing community of inventors

Santa Clara, CA, United States of America

Anthony J Abbate